Pfizer (NYSE:PFE) shares fell on Wednesday ... Two days after former President Joe Biden’s election win, the company said its messenger RNA-based shot generated promising early results against ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

In March, short sellers collectively increased their negative bets on the broader healthcare industry, as indicated by a rise ...

The ruling represents a major milestone in the ongoing patent dispute between CureVac and BioNTech in Germany, which involves a total of six intellectual property rights related to messenger RNA ...

While Australia's healthcare system often faces criticism it ranks first among OECD countries for equity and healthcare outcomes, and holds third place for overall healthcare performance.

Objective To estimate the effectiveness of messenger RNA (mRNA) booster doses during the period of ... vaccines against infection (regardless of symptoms) and against COVID-19-related hospitalisation ...

Thirty cases of new-onset MCD after COVID-19 vaccination have been reported worldwide, including 16 cases related to the Pfizer-BioNTech vaccine ... of new-onset MCD following the Moderna messenger ...

Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments ...

Pfizer has axed its oral GLP-1 asset danuglipron after one patient had potential drug-induced liver injury in a phase 1 trial. The setback blows a hole in the Big Pharma’s plans to challenge for ...

RELATED: Pfizer to pay nearly $60M over kickbacks for migraine drug once promoted by Lady Gaga A Pfizer spokesperson told the AP that Pfizer will stop testing danuglipron in combination with other ...

Scientists have transformed RNA, a biological molecule present in all living cells, into a biosensor that can detect tiny chemicals relevant to human health. Research by Rutgers University-New ...